Bryja V, Červenka I, Čajánek L. The connections of Wnt pathway components with cell cycle and centrosome: side effects or a hidden logic? Crit Rev Biochem Mol Biol. 2017;52(6):614–37.
CAS PubMed PubMed Central Article Google Scholar
Tai D, Wells K, Arcaroli J, Vanderbilt C, Aisner D, Messersmith W, et al. Targeting the WNT Signaling Pathway in Cancer Therapeutics. Oncologist. 2015;20(10):1189–98.
CAS PubMed PubMed Central Article Google Scholar
Miete C, Solis G, Koval A, Brückner M, Katanaev V, Behrens J, et al. Gαi2-induced conductin/axin2 condensates inhibit Wnt/β-catenin signaling and suppress cancer growth. Nat Commun. 2022;13(1):674.
CAS PubMed PubMed Central Article Google Scholar
Parichha A, Suresh V, Chatterjee M, Kshirsagar A, Ben-Reuven L, Olender T, et al. Constitutive activation of canonical Wnt signaling disrupts choroid plexus epithelial fate. Nat Commun. 2022;13(1):633.
CAS PubMed PubMed Central Article Google Scholar
Neiheisel A, Kaur M, Ma N, Havard P, Shenoy AK. Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials. Int J Cancer. 2022;150(5):727–40.
CAS PubMed Article Google Scholar
Nusse R, Clevers H. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities. Cell. 2017;169(6):985–99.
CAS PubMed Article Google Scholar
Shi J, Li F, Luo M, Wei J, Liu X. βDistinct Roles of Wnt/−Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. Mediat Inflamm. 2017;2017:3520581.
Tewari D, Bawari S, Sharma S, DeLiberto L, Bishayee A. Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy. Pharmacol Ther. 2021;227:107876.
CAS PubMed Article Google Scholar
Silva-García O, Valdez-Alarcón J, Baizabal-Aguirre V. Wnt/β-Catenin Signaling as a Molecular Target by Pathogenic Bacteria. Front Immunol. 2019;10:2135.
PubMed PubMed Central Article CAS Google Scholar
Kwon C, Cheng P, King I, Andersen P, Shenje L, Nigam V, et al. Notch post-translationally regulates β-catenin protein in stem and progenitor cells. Nat Cell Biol. 2011;13(10):1244–51.
CAS PubMed PubMed Central Article Google Scholar
Raisch J, Côté-Biron A, Langlois M, Leblanc C, Rivard N. Unveiling the Roles of Low-Density Lipoprotein Receptor-Related Protein 6 in Intestinal Homeostasis, Regeneration and Oncogenesis. Cells. 2021;10(7):1792.
CAS PubMed PubMed Central Article Google Scholar
Gómez-Orte E, Sáenz-Narciso B, Moreno S, Cabello J. Multiple functions of the noncanonical Wnt pathway. Trends Genet. 2013;29(9):545–53.
PubMed Article CAS Google Scholar
Yamamoto D, Oshima H, Wang D, Takeda H, Kita K, Lei X, et al. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer. J Pathol. 2022;257(1):39–52.
CAS PubMed Article Google Scholar
Zhang Y, Wang X. Targeting the Wnt/β-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13(1):165.
PubMed PubMed Central Article Google Scholar
Steinhart Z, Angers S. Wnt signaling in development and tissue homeostasis. Development. 2018;145(11):dev146589.
PubMed Article CAS Google Scholar
Menck K, Heinrichs S, Baden C, Bleckmann A. The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention. Cells. 2021;10(1):142.
CAS PubMed PubMed Central Article Google Scholar
Zhang X, Yao J, Shi H, Gao B, Zhou H, Zhang Y, et al. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway. Cell Death Dis. 2021;12(9):802.
CAS PubMed PubMed Central Article Google Scholar
Lepore Signorile M, Grossi V, Di Franco S, Forte G, Disciglio V, Fasano C, et al. Pharmacological targeting of the novel β-catenin chromatin-associated kinase p38α in colorectal cancer stem cell tumorspheres and organoids. Cell Death Dis. 2021;12(4):316.
CAS PubMed PubMed Central Article Google Scholar
Ji Z, Mi A, Li M, Li Q, Qin C. Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer. J Cancer. 2021;12(7):2030–40.
CAS PubMed PubMed Central Article Google Scholar
Li N, Li J, Mi Q, Xie Y, Li P, Wang L, et al. Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/β-catenin signalling pathway and is a potential diagnostic biomarker. J Cell Mol Med. 2020;24(19):11318–29.
CAS PubMed PubMed Central Article Google Scholar
Liu R, Deng P, Zhang Y, Wang Y, Peng C. Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/β-catenin pathway. World J Surg Oncol. 2021;19(1):51.
PubMed PubMed Central Article Google Scholar
Kajino-Sakamoto R, Fujishita T, Taketo M, Aoki M. Synthetic lethality between MyD88 loss and mutations in Wnt/β-catenin pathway in intestinal tumor epithelial cells. Oncogene. 2021;40(2):408–20.
CAS PubMed Article Google Scholar
Huang D, Xiao F, Hao H, Hua F, Luo Z, Huang Z, et al. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level. Cell Commun Signal. 2020;18(1):169.
CAS PubMed PubMed Central Article Google Scholar
Gu Y, Gu J, Shen K, Zhou H, Hao J, Li F, et al. HOXA13 promotes colon cancer progression through β-catenin-dependent WNT pathway. Exp Cell Res. 2020;395(2):112238.
CAS PubMed Article Google Scholar
Zhu Y, Bian Y, Zhang Q, Hu J, Li L, Yang M, et al. LINC00365 promotes colorectal cancer cell progression through the Wnt/β-catenin signaling pathway. J Cell Biochem. 2020;121(2):1260–72.
CAS PubMed Article Google Scholar
Yan R, Fan X, Xiao Z, Liu H, Huang X, Liu J, et al. Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-Catenin activity and cancer stemness. Cancer Lett. 2022;531:83–97.
CAS PubMed Article Google Scholar
Zhang W, Ruan X, Li Y, Zhi J, Hu L, Hou X, et al. KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway. Theranostics. 2022;12(4):1500–17.
CAS PubMed PubMed Central Article Google Scholar
Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 2007;19(2):150–8.
CAS PubMed Article Google Scholar
Xue G, Romano E, Massi D, Mandalà M. Wnt/β-catenin signaling in melanoma: Preclinical rationale and novel therapeutic insights. Cancer Treat Rev. 2016;49:1–12.
CAS PubMed Article Google Scholar
Atlasi Y, Looijenga L, Fodde R. Cancer stem cells, pluripotency, and cellular heterogeneity: a WNTer perspective. Curr Top Dev Biol. 2014;107:373–404.
CAS PubMed Article Google Scholar
Li J, Ji L, Chen J, Zhang W, Ye Z. Wnt/β-Catenin Signaling Pathway in Skin Carcinogenesis and Therapy. Biomed Res Int. 2015;2015:964842.
PubMed PubMed Central Google Scholar
Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol. 2019;234(6):8381–95.
CAS PubMed Article Google Scholar
Wend P, Wend K, Krum S, Miranda-Carboni G. The role of WNT10B in physiology and disease. Acta Physiol. 2012;204(1):34–51.
Kim J, Park S, Jun Y, Kim J, Nam J. Roles of Wnt Target Genes in the Journey of Cancer Stem Cells. Int J Mol Sci. 2017;18(8):1604.
PubMed Central Article CAS Google Scholar
Vadde R, Vemula S, Jinka R, Merchant N, Bramhachari P, Nagaraju G. Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer. Crit Rev Oncol Hematol. 2017;113:22–7.
Petherick K, Williams A, Lane J, Ordóñez-Morán P, Huelsken J, Collard T, et al. Autolysosomal β-catenin degradation regulates Wnt-autophagy-p62 crosstalk. EMBO J. 2013;32(13):1903–16.
CAS PubMed PubMed Central Article Google Scholar
Gao C, Cao W, Bao L, Zuo W, Xie G, Cai T, et al. Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol. 2010;12(8):781–90.
留言 (0)